Aptevo Therapeutics Inc.
APVO
$4.39
-$0.39-8.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.23% | -6.93% | 19.45% | 25.98% | -346.45% |
| Total Depreciation and Amortization | -42.45% | -38.79% | -31.71% | -39.33% | -40.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.97% | -120.11% | -67.25% | -41.29% | -22.27% |
| Change in Net Operating Assets | 36.45% | 214.77% | 27.01% | -125.06% | -193.04% |
| Cash from Operations | 1.14% | -9.63% | 16.31% | -28.11% | -245.66% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 120.47% | 13.01% | 725.36% | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 120.62% | 13.01% | 725.16% | 99.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.19% | 143.54% | 83.49% | 49.47% | -347.09% |